{
    "2019-04-04": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Medical Marijuana Stocks to Cure Your Portfolio",
                "features": {
                    "keywords": [
                        "Medical",
                        "Marijuana",
                        "Stocks",
                        "Cure",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "AbbVie Announces New Formulary Listings for its Hepatitis C Treatment MAVIRETâ„¢",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Formulary",
                        "Listings",
                        "Hepatitis",
                        "C",
                        "Treatment",
                        "MAVIRET"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Novartis Resubmits BLA to FDA for Biosimilar of Neulasta",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Resubmits",
                        "BLA",
                        "FDA",
                        "Biosimilar",
                        "Neulasta"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}